Biogenic amines and psychiatry.
D006916:5-Hydroxytryptophan / Q000378:metabolism; D000342:Affective Symptoms / Q000139:chemically induced; D000588:Amines / Q000378:metabolism*; D000661:Amphetamine / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000378:metabolism; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy; D001361:Avitaminosis / Q000378:metabolism; D001679:Biogenic Amines / Q000378:metabolism; D001921:Brain / Q000378:metabolism*; D001923:Brain Chemistry; D004298:Dopamine / Q000378:metabolism; D004837:Epinephrine / Q000378:metabolism; D006213:Hallucinogens / Q000494:pharmacology; D006801:Humans; D001523:Mental Disorders / Q000209:etiology* / Q000378:metabolism; D008661:Metabolism, Inborn Errors / Q000209:etiology; D009638:Norepinephrine / Q000378:metabolism; D012559:Schizophrenia / Q000378:metabolism; D012701:Serotonin / Q000378:metabolism; D012893:Sleep Wake Disorders / Q000378:metabolism; D014363:Tryptamines / Q000378:metabolism
D000588:Amines; D001679:Biogenic Amines; D006213:Hallucinogens; D014363:Tryptamines; D012701:Serotonin; D006916:5-Hydroxytryptophan; D000661:Amphetamine; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine